We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+3.78%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$274M
AUM Growth
-$6.67M
Cap. Flow
-$848K
Cap. Flow %
-0.31%
Top 10 Hldgs %
29.37%
Holding
164
New
33
Increased
27
Reduced
41
Closed
27

Top Buys

Rank Stock Value
1
CTLT
CATALENT, INC.
CTLT
+$4.22M
2
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$4.16M
3
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$4.05M
4
CRM icon
Salesforce
CRM
+$2.28M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.1M

Top Sells

Rank Stock Value
1
SP
SP Plus Corporation
SP
+$4.12M
2
OFIX icon
Orthofix Medical
OFIX
+$2.44M
3
IDYA icon
IDEAYA Biosciences
IDYA
+$2.31M
4
IMCR icon
Immunocore
IMCR
+$2.26M
5
NUVL
Nuvalent
NUVL
+$2.23M

Sector Composition

Rank Sector Weight
1 Healthcare 43.71%
2 Technology 17%
3 Consumer Discretionary 6.54%
4 Energy 4.11%
5 Consumer Staples 3.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RTX icon
51
RTX Corp
RTX
$302B
$1.76M 0.64%
17,500
-12,800
-42% -$1.32M
CRBP icon
52
Corbus Pharmaceuticals
CRBP
$177M
$1.76M 0.64%
+38,793
New +$1.63M
DVAX
53
DELISTED
Dynavax Technologies
DVAX
$1.75M 0.64%
156,161
– –
MRC
54
DELISTED
MRC Global
MRC
$1.74M 0.63%
134,600
-45,800
-25% -$573K
ADBE icon
55
Adobe
ADBE
$109B
$1.72M 0.63%
+3,100
New +$1.5M
PFE icon
56
Pfizer
PFE
$154B
$1.69M 0.62%
+60,300
New +$1.66M
LAUR icon
57
Laureate Education
LAUR
$5.13B
$1.67M 0.61%
112,107
-51,400
-31% -$769K
ITCI
58
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.67M 0.61%
24,337
– –
KNSA icon
59
Kiniksa Pharmaceuticals
KNSA
$5.97B
$1.66M 0.6%
88,688
– –
HDB icon
60
HDFC Bank
HDB
$120B
$1.61M 0.59%
50,082
+9,600
+24% +$281K
CRNX icon
61
Crinetics Pharmaceuticals
CRNX
$8.93B
$1.58M 0.58%
35,237
+19,338
+122% +$893K
GDX icon
62
VanEck Gold Miners ETF
GDX
$27.6B
$1.57M 0.57%
46,200
-41,600
-47% -$1.43M
NU icon
63
Nu Holdings
NU
$67B
$1.56M 0.57%
121,061
+20,600
+21% +$240K
RVMD icon
64
Revolution Medicines
RVMD
$44.4B
$1.56M 0.57%
40,083
+25,758
+180% +$963K
WCC
65
WESCO International
WCC
$17.9B
$1.55M 0.57%
9,797
-4,400
-31% -$749K
DUOL icon
66
Duolingo
DUOL
$6.42B
$1.54M 0.56%
7,400
+2,400
+48% +$491K
WMT icon
67
Walmart Inc
WMT
$897B
$1.52M 0.56%
22,500
+4,400
+24% +$277K
IBN icon
68
ICICI Bank
IBN
$108B
$1.5M 0.55%
52,147
+9,700
+23% +$260K
NVDA icon
69
NVIDIA
NVDA
$5.27T
$1.48M 0.54%
+12,000
New +$1.21M
LQDA icon
70
Liquidia Corp
LQDA
$8.1B
$1.46M 0.53%
+121,754
New +$1.62M
AER icon
71
AerCap
AER
$23.5B
$1.45M 0.53%
+15,600
New +$1.39M
IDYA icon
72
IDEAYA Biosciences
IDYA
$3.54B
$1.43M 0.52%
40,856
-58,436
-59% -$2.31M
SE icon
73
Sea Limited
SE
$70.3B
$1.38M 0.5%
19,341
-600
-3% -$39.6K
GPCR icon
74
Structure Therapeutics
GPCR
$3.82B
$1.38M 0.5%
35,128
-2,316
-6% -$95.1K
LYV icon
75
Live Nation Entertainment
LYV
$43B
$1.37M 0.5%
+14,600
New +$1.38M
1 2
3
4 5

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $363M AUM 34.89% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

HighVista Strategies's Q2 2024 Portfolio in Review

As of Q2 2024, HighVista Strategies held 164 positions worth $274M, down 2.4% from $280M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

HighVista Strategies's Q2 2024 filing shows 33 new, 27 increased, 41 reduced and 27 closed positions. Its largest new stake was CATALENT, INC.: 75,600 shares worth $4.25M. The largest sale was SP Plus Corporation, an estimated $4.12M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 45% a quarter earlier, followed by Technology and Consumer Discretionary.

  • HighVista Strategies's largest Q2 2024 buy was CATALENT, INC.: 75,600 shares worth $4.25M.
  • HighVista Strategies added most to Salesforce in Q2 2024, an estimated $2.28M increase.
  • HighVista Strategies's biggest Q2 2024 reduction was IDEAYA Biosciences, cutting an estimated $2.31M.
  • HighVista Strategies fully exited SP Plus Corporation in Q2 2024, selling an estimated $4.12M.
  • HighVista Strategies's ten largest holdings make up 29% of its $274M portfolio in Q2 2024.
  • HighVista Strategies opened 33 new positions and closed 27 in Q2 2024.
  • HighVista Strategies's portfolio value fell 2.4% quarter-over-quarter to $274M.

Based on HighVista Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.